NRx Pharmaceuticals, Inc.
NASDAQ:NRXPBiotechnology
+$0.06 today
- Market cap
- $124.12M
- Beta
- 2.19
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$0.76
Volume 2.09M
Average 1.27M
NRXP Intangible Assets
Identifiable non-physical assets such as patents, trademarks, licenses, and customer relationships.
NRx Pharmaceuticals, Inc.NASDAQ: NRXP
Intangible Assets · Q1 FY2026 · quarter ended Mar 2026
Intangible assets remains negative
Q1 FY2026 intangible assets was $879K, compared with $0 a year earlier.
Context
- Intangible assets amounted to 7.4% of total assets at the end of Q1 FY2026, up 7.4 pp from a year earlier.
- Intangible assets increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Intangible Assets history
USD · from the balance sheet
- Latest · FY2025
- 925K USD
- Year-over-year change
- —
| Period | Period end | Intangible Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 925K | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Intangible Assets vs competitors
How NRXP compares with its peers on the latest reported figures
- NRXP's Mar 2026 intangible assets of $879K is the 2nd highest of the 9 companies compared; the peer median is $0.
- Intangible assets amounts to 7.4% of total assets for NRXP, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $34.2M | +0.0% | — | 10.5% | |
| Mar 2026 | $879K | — | — | 7.4% | |
| Mar 2026 | $316.09K | -36.4% | -53.3% | 1.6% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NRXP) | $0 | -18.2% | -53.3% | 0.0% | |
Competitors are the stored peer set for NRXP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
Intrinsic Alpha fair value
Locked
Current Price
$2.80
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.